Triumph Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,971
| Closed | -$485K | – | 239 |
|
|
2023
Q4 | $485K | Sell |
12,971
-155
| -1% | -$5.8K | 0.21% | 102 |
|
|
2023
Q3 | $480K | Buy |
13,126
+470
| +4% | +$17.2K | 0.22% | 105 |
|
|
2023
Q2 | $456K | Sell |
12,656
-332
| -3% | -$12K | 0.21% | 104 |
|
|
2023
Q1 | $462K | Buy |
12,988
+1,223
| +10% | +$43.5K | 0.24% | 82 |
|
|
2022
Q4 | $413K | Sell |
11,765
-9,840
| -46% | -$346K | 0.22% | 108 |
|
|
2022
Q3 | $641K | Buy |
21,605
+16,868
| +356% | +$500K | 0.35% | 64 |
|
|
2022
Q2 | $258K | Buy |
+4,737
| New | +$258K | 0.14% | 158 |
|